HealthCo Healthcare & Wellness REIT (ASX: HCW) has partnered with a new unlisted fund to acquire a 100% stake in 11 private hospitals leased to Healthscope, for a purchase price of AU$1.2 Billion. The acquisition will see HCW take a 100% interest in four hospitals for AU$256 Million in the first tranche, with the unlisted fund acquiring seven hospitals for AU$944 Million in the second and third tranches, with HCW taking a ~50% equity interest in the unlisted fund.
The deal will be funded by an AU$320 Million underwritten equity raising, comprising an AU$89 Million institutional placement and an AU$231 Million pro-rata accelerated non-renounceable entitlement offer. The acquisition, which has attractive lease terms, will significantly improve the income security, scale and quality of HCW’s portfolio, while the unlisted fund will provide funding to unlock AU$1 Billion of accretive development opportunities post-acquisition with a target ROIC of 6-8%. The deal is expected to be accretive to FFO, with FFO guidance for FY23 being upgraded to 7.6cpu.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.